Elena Ballarín

Summary

Country: Spain

Publications

  1. ncbi request reprint Cyanamide-induced aplastic anemia
    Elena Ballarín
    Fundació Institut Català de Farmacologia Servei de Farmacologia Clínica, Hospital Universitari Vall d Hebron Universitat Autonoma de Barcelona, P Vall d Hebron 129 139, 08035, Barcelona, Spain
    Eur J Clin Pharmacol 61:467-9. 2005
  2. ncbi request reprint Population-based drug-induced agranulocytosis
    Luisa Ibáñez
    Fundacio Institut Catala de Farmacologia, Universitat Autonoma de Barcelona, Clinical Pharmacology Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Arch Intern Med 165:869-74. 2005
  3. ncbi request reprint Agranulocytosis associated with dipyrone (metamizol)
    Luisa Ibáñez
    Fundacio Institut Catala de Farmacologia, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Department of Pharmacology, Therapeutics and Toxicology, Institut Catala de la Salut, Universitat Autonoma de Barcelona, Barcelona, Spain
    Eur J Clin Pharmacol 60:821-9. 2005
  4. doi request reprint Antiepileptic drugs and suicide: a systematic review of adverse effects
    Pili Ferrer
    Fundacio Institut Catala de Farmacologia, Barcelona, Spain
    Neuroepidemiology 42:107-20. 2014
  5. doi request reprint Epidemiology of aplastic anemia: a prospective multicenter study
    Eva Montané
    Fundacio Institut Catala de Farmacologia, Barcelona, Spain
    Haematologica 93:518-23. 2008

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Cyanamide-induced aplastic anemia
    Elena Ballarín
    Fundació Institut Català de Farmacologia Servei de Farmacologia Clínica, Hospital Universitari Vall d Hebron Universitat Autonoma de Barcelona, P Vall d Hebron 129 139, 08035, Barcelona, Spain
    Eur J Clin Pharmacol 61:467-9. 2005
    ..One year after hospital admission, the patient was completely recovered with no need of immunosuppressive therapy. An objective causality assessment revealed that an adverse drug reaction was probable...
  2. ncbi request reprint Population-based drug-induced agranulocytosis
    Luisa Ibáñez
    Fundacio Institut Catala de Farmacologia, Universitat Autonoma de Barcelona, Clinical Pharmacology Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Arch Intern Med 165:869-74. 2005
    ..Since the publication of a major international case-control study on the risk of agranulocytosis associated with the use of medicines in the 1980s, many new drugs have been introduced in therapeutics...
  3. ncbi request reprint Agranulocytosis associated with dipyrone (metamizol)
    Luisa Ibáñez
    Fundacio Institut Catala de Farmacologia, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Department of Pharmacology, Therapeutics and Toxicology, Institut Catala de la Salut, Universitat Autonoma de Barcelona, Barcelona, Spain
    Eur J Clin Pharmacol 60:821-9. 2005
    ..Reported estimates of the risk of agranulocytosis associated with metamizol have varied by several orders of magnitude. We assessed this association in a large database for the surveillance of blood dyscrasias...
  4. doi request reprint Antiepileptic drugs and suicide: a systematic review of adverse effects
    Pili Ferrer
    Fundacio Institut Catala de Farmacologia, Barcelona, Spain
    Neuroepidemiology 42:107-20. 2014
    ..This systematic review (SR) gives an updated approach to this health issue...
  5. doi request reprint Epidemiology of aplastic anemia: a prospective multicenter study
    Eva Montané
    Fundacio Institut Catala de Farmacologia, Barcelona, Spain
    Haematologica 93:518-23. 2008
    ..Aplastic anemia is a rare and severe disease. Its incidence varies considerably worldwide. We aimed at describing the epidemiology of this disease, including the incidence, mortality and survival trends, in a well-defined population...